Phase I / II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large-cell lymphoma (Q35051886)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I / II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large-cell lymphoma |
scientific article |
Statements
1 reference
Phase I / II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large-cell lymphoma (English)
1 reference
Tomohiro Aoki
1 reference
Kiyohiko Hatake
1 reference
Michinori Ogura
1 reference
Kensei Tobinai
1 reference
Kenichi Ishizawa
1 reference
Naokuni Uike
1 reference
Toshiki Uchida
1 reference
Tatsuya Suzuki
1 reference
Takashi Watanabe
1 reference
Dai Maruyama
1 reference
Masahiro Yokoyama
1 reference
Takatoshi Takubo
1 reference
Hideaki Kagehara
1 reference
Takafumi Matsushima
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference